Taysha Gene Therapies, Inc.

TSHA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001806310

SEC filings (opens in a new tab)

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Taysha Gene Therapies, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of TSHA: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Q1 2024	Change
Holders	87	109	+22
Shares	130.1M	140.2M	+10.0M (+7.7%)
Value	$230.3M	$402.2M	+$171.9M (+74.6%)

New holders (36)

Institutions that held Taysha Gene Therapies, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to TSHA in Q1 2024
Institution	Shares	Value	% of portfolio
Octagon Capital Advisors LP	3,030,000	$8.70M	1.06%
Eagle Asset Management Inc	1,789,394	$5.08M	0.03%
Cowen and Company, LLC	1,550,000	$4.45M	0.17%
StemPoint Capital LP	1,087,785	$3.12M	0.83%
Marshall Wace, LLP	1,030,657	$2.96M	0.00%
Soleus Capital Management, L.P.	925,000	$2.65M	0.23%
HRT Financial LP	414,980	$1.19M	0.01%
Marathon Trading Investment Management LLC	223,900	$642.6K	0.25%
Balyasny Asset Management LLC	188,698	$541.6K	0.00%
Point72 Asia (Singapore) Pte. Ltd.	181,306	$520.3K	0.14%
Brevan Howard Capital Management LP	172,769	$495.8K	0.05%
Laurion Capital Management LP	164,258	$471.4K	0.01%
ExodusPoint Capital Management, LP	112,077	$322.0K	0.00%
Y-Intercept (Hong Kong) Ltd	97,054	$278.5K	0.02%
Old Mission Capital LLC	76,419	$219.3K	0.01%
GTS Securities LLC	61,352	$176.1K	0.00%
Jump Financial, LLC	54,090	$155.2K	0.00%
Jefferies Financial Group Inc.	48,100	$138.0K	0.00%
LMR Partners LLP	32,485	$93.2K	0.00%
CTC Alternative Strategies, Ltd.	29,800	$85.5K	0.05%
Omers Administration Corp	28,000	$80.4K	0.00%
Polymer Capital Management (HK) LTD	27,680	$79.4K	0.02%
Cannon Global Investment Management, LLC	24,200	$69.5K	0.19%
DRW Securities, LLC	17,800	$51.1K	0.00%
US Bancorp	17,638	$50.6K	0.00%
Cambridge Investment Research Advisors, Inc.	17,290	$50.0K	0.00%
StoneX Group Inc.	14,382	$41.3K	0.00%
Walleye Capital LLC	13,000	$37.3K	0.00%
TradeLink Capital LLC	11,300	$32.0K	0.48%
Twinbeech Capital LP	10,204	$29.3K	0.00%
Symmetry Investments LP	10,100	$29.0K	0.00%
Headlands Technologies LLC	2,315	$6.64K	0.00%
Daiwa Securities Group Inc.	691	$2.00K	0.00%
Aquatic Capital Management LLC	400	$1.15K	0.00%
Riggs Asset Managment Co. Inc.	198	$569	0.00%
Macquarie Group Ltd	8,066	$23	0.00%

Sold out (14)

Institutions that held Taysha Gene Therapies, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of TSHA in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
TCG Crossover Management, LLC	2,912,861	$5.16M
Exome Asset Management LLC	693,300	$1.23M
Monaco Asset Management SAM	295,000	$522.1K
Polar Asset Management Partners Inc.	186,700	$330.5K
Bank of New York Mellon Corp	58,140	$102.9K
Redwood Wealth Management Group, LLC	42,600	$75.4K
Graham Capital Management, L.P.	28,477	$50.4K
Virtu Financial LLC	26,070	$46.0K
Dynamic Technology Lab Private Ltd	17,389	$31.0K
Two Sigma Securities, LLC	17,202	$30.4K
Group One Trading, L.P.	12,032	$21.3K
Camelot Portfolios, LLC	11,000	$19.5K
Royal Capital Wealth Management, LLC	10,665	$18.9K
Signaturefd, LLC	50	$89